-Business Standard Commerce Minister Nirmala Sitharaman says India's proposals will be now reviewed by the WTO General Council Washington: India has reached an agreement with the United States on public stockpiling of food, trade minister Nirmala Sithamaran said on Thursday, paving the way for the implementation of a global trade facilitation deal that has been stalled for months. Under the pact with Washington, India will lift a veto on a global agreement on...
More »SEARCH RESULT
Total Matching Records found : 1504
Chhattisgarh sterilisation camp toll climbs to 11, 50 still critical -Ejaz Kaiser
-The Hindustan Times Raipur (Chhattisgarh): Eleven women have died and dozens more are in a critical condition after a government-run sterilisation programme in Chhattisgarh designed to control the country's billion-plus population went wrong, officials said on Tuesday. More than 50 women are seriously ill after suffering complications from the surgery in Bilaspur district over the weekend, authorities in Chhattisgarh said. "Reports of a drop in pulse, vomiting and other ailments started...
More »Smog scare: Patients told to stay indoors
-The Times of India NEW DELHI: Air quality in the city is deteriorating every day as agricultural waste burning continues unabated in Punjab and Haryana. Doctors, too, are seeing a jump in cases of acute bronchitis, chronic obstructive pulmonary diseases (COPD) and asthma. They are advising those who are vulnerable or already suffering from respiratory disorders to avoid going out during peak traffic hours, keeping inhalers handy and, if smog is...
More »NRIs filed 78% of the patent pleas in India -Sushmi Dey
-The Times of India NEW DELHI: India registered the third highest rate for patent filings by non-residents at 78% of the total applications, ahead of China at 18%, Japan at 16% and the US at 50%, the latest data from the Indian patent office showed. Canada and Brazil topped the list with 86.6% and 84%, respectively. Officials opine this is an indicator of lack of awareness amongst the domestic industry as well...
More »New hepatitis drug to cost more in middle income nations; activists cry foul -Jyotsna Singh
-Down to Earth Pharma company's strategy of different prices for different countries to affect quality treatment of 185 million people infected with Hepatitis C worldwide Health activists and agencies on Tuesday criticised leading pharmaceutical company Bristol-Myers Squibb (BMS)'s commercial strategy to sell new Hepatitis C Medicine Daclatasvir, stating it would exclude a large number of patients who cannot afford expensive treatment. BMS had announced that it would create a tiered pricing strategy for...
More »
